Results 231 to 240 of about 251,912 (281)
Some of the next articles are maybe not open access.

Related searches:

Performance of a new 1MV AMS facility (AURiS) at PRL, Ahmedabad, India

Nuclear Instruments and Methods in Physics Reseach B, 2019
A 1 MV Accelerator Mass Spectrometer (AMS) has been installed at Physical Research Laboratory (PRL), Ahmedabad, India which is tuned for measurement of 14C, 10Be and 26Al and is fully operational.
R. Bhushan   +3 more
semanticscholar   +1 more source

Mouse PRL-2 and PRL-3, Two Potentially Prenylated Protein Tyrosine Phosphatases Homologous to PRL-1

Biochemical and Biophysical Research Communications, 1998
Protein tyrosine phosphatases (PTPs) play a fundamental role in regulating diverse cellular processes. PRL-1 is a unique nuclear PTP that is induced in mitogen-stimulated cells and regenerating liver. Database searches using the PRL-1 sequence led to the identification of mouse PRL-2 and PRL-3 which exhibit 87% and 76% identity to mouse PRL-1 in their ...
Q, Zeng, W, Hong, Y H, Tan
openaire   +2 more sources

Anti‐prolactin (PRL) autoantibodies suppress PRL bioactivity in patients with macroprolactinaemia

Clinical Endocrinology, 2007
SummaryObjective  Macroprolactinaemia, mainly caused by anti‐prolactin (PRL) autoantibodies, is frequently found in patients with hyperprolactinaemia. Characteristically, these patients lack clinical symptoms of hyperprolactinaemia, but the serum bioactive PRL concentrations in vitro measured by the Nb2 bioassay are usually high.
Naoki, Hattori   +5 more
openaire   +2 more sources

Immunoelectron microscopic observation of prolactin (PRL) in human PRL secreting pituitary adenomas and non-neoplastic pituitary PRL cells

Pathology - Research and Practice, 1988
Immunoelectron microscopic localization of prolactin (PRL) was studied in pituitary adenoma cells and in non-neoplastic PRL cells. The adenoma cells showed characteristic concentration of PRL in Golgi region which was ultrastructurally in Golgi saccules and in vesicular RER.
openaire   +2 more sources

Home - About - Disclaimer - Privacy